Clinical study of different interventional treatments for primary hepatocellular carcinoma based on propensity-score matching

doi:10.4240/wjgs.v16.i11.3463

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 11

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (264)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-2) series, Tables (1-4) series.

Item

Count

PDF

HTML

166

Figures (1-2)

Tables (1-4)

Sum=257

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

Sum=1

Nov 27, 2024 (publication date) through Nov 24, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Surgery

ISSN

1948-9366

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Gastrointest Surg. Nov 27, 2024; 16(11): 3463-3470
Published online Nov 27, 2024. doi: 10.4240/wjgs.v16.i11.3463

Full Size Figure Download Figure

Figure 2 Comparison of the levels of serum tumor markers between the two groups. A: Comparison of alpha-fetoprotein levels between the two groups; B: Comparison of carbohydrate antigen-199 levels between the two groups; C: Comparison of carcinoembryonic antigen levels between the two groups. AFP: Alpha-fetoprotein; CA199: Carbohydrate antigen-199; CEA: Carcinoembryonic antigen. ^fP < 0.000001.

Citation: Cheng XB, Yang L, Lu MQ, Peng YB, Wang L, Zhu SM, Hu ZW, Wang ZL, Yang Q. Clinical study of different interventional treatments for primary hepatocellular carcinoma based on propensity-score matching. World J Gastrointest Surg 2024; 16(11): 3463-3470
URL: https://www.wjgnet.com/1948-9366/full/v16/i11/3463.htm
DOI: https://dx.doi.org/10.4240/wjgs.v16.i11.3463